PMID- 18693614
OWN - NLM
STAT- MEDLINE
DCOM- 20081009
LR  - 20080812
IS  - 1025-9589 (Print)
IS  - 1025-9589 (Linking)
VI  - 19
IP  - 4
DP  - 2007 Oct-Dec
TI  - Large B cell lymphoma--year by year.
PG  - 121-6
AB  - Non Hodgkin's Lymphoma (NHL) comprises a group of lymphoproliferative disorders 
      the frequency of which continues to rise. Although many classification systems 
      exist for identifying specific histological subtypes, NHL is generally divided 
      into indolent (low-grade) and aggressive (intermediate- and high-grade) forms. 
      Large B Cell Lymphoma (LBCL) is one of the commonest aggressive NHLs. The aim of 
      this review is to provide a general overview of NHL, its clinically practicable 
      cellular classification, epidemiology and in depth overview of the evolution of 
      treatment of LBCL during the past 5 years. Current guidelines from National 
      Cancer Institute (NCI), USA and National Institute on Clinical Excellence (NICE), 
      UK are mentioned and recommendations according to our own set-up are suggested.
FAU - Syed, Abdus Samad
AU  - Syed AS
AD  - Department of Oncology, Combined Military Hospital, Rawalpindi, Pakistan.
FAU - Samad, Fauzia Abdus
AU  - Samad FA
FAU - ur Rahman, Mahmood
AU  - ur Rahman M
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Pakistan
TA  - J Ayub Med Coll Abbottabad
JT  - Journal of Ayub Medical College, Abbottabad : JAMC
JID - 8910750
SB  - IM
MH  - Humans
MH  - *Lymphoma, Large B-Cell, Diffuse/diagnosis/epidemiology/therapy
RF  - 45
EDAT- 2008/08/13 09:00
MHDA- 2008/10/10 09:00
CRDT- 2008/08/13 09:00
PHST- 2008/08/13 09:00 [pubmed]
PHST- 2008/10/10 09:00 [medline]
PHST- 2008/08/13 09:00 [entrez]
PST - ppublish
SO  - J Ayub Med Coll Abbottabad. 2007 Oct-Dec;19(4):121-6.